Vaxcyte
PCVX
Vaxcyte (PCVX) earnings history
Most recent quarter
- Fiscal period
- Q4 2025
- Period end
- Dec 31, 2025
- EPS actual
- −$1.81
- EPS estimate
- −$1.53
- EPS surprise
- −18.32%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Feb 24, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2025 | Feb 24, 2026 | −$1.53 | −$1.81 | −18.32% | $0.00 | SEC |
| Q2 2025 | Aug 6, 2025 | −$1.16 | −$1.22 | −5.17% | $0.00 | SEC |
| Q1 2025 | May 7, 2025 | −$1.06 | −$1.04 | +2.02% | $0.00 | SEC |
| Q4 2024 | Feb 25, 2025 | −$1.11 | −$1.02 | +7.82% | $0.00 | SEC |
| Q3 2024 | Nov 5, 2024 | −$1.10 | −$0.83 | +24.60% | $0.00 | SEC |
| Q2 2024 | Aug 6, 2024 | −$0.98 | −$1.10 | −12.75% | $0.00 | SEC |
| Q1 2024 | May 8, 2024 | −$1.13 | −$0.85 | +24.70% | $0.00 | SEC |
| Q4 2023 | Feb 27, 2024 | −$1.05 | −$1.83 | −73.56% | $0.00 | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.84 | −$0.91 | −8.63% | $0.00 | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.75 | −$0.70 | +6.04% | $0.00 | SEC |
| Q1 2023 | May 8, 2023 | −$0.82 | −$0.70 | +14.85% | $0.00 | SEC |
| Q4 2022 | Feb 27, 2023 | −$0.93 | −$1.03 | −10.75% | $0.00 | SEC |
| Q3 2022 | Nov 7, 2022 | −$0.84 | −$0.93 | −11.15% | $0.00 | SEC |
| Q2 2022 | Aug 8, 2022 | −$0.69 | −$0.80 | −15.94% | $0.00 | SEC |
| Q1 2022 | May 9, 2022 | −$0.63 | −$0.68 | −8.50% | $0.00 | SEC |
| Q4 2021 | Feb 28, 2022 | −$0.56 | −$0.55 | +1.79% | $0.00 | SEC |
| Q3 2021 | Nov 10, 2021 | −$0.55 | −$0.51 | +6.71% | $0.00 | SEC |
| Q2 2021 | Aug 11, 2021 | −$0.52 | −$0.46 | +12.10% | $0.00 | SEC |
| Q1 2021 | May 11, 2021 | −$0.51 | −$0.41 | +19.61% | $0.00 | SEC |
| Q4 2020 | Mar 29, 2021 | −$0.54 | −$0.41 | +24.07% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Vaxcyte (PCVX) last report earnings?
Vaxcyte last reported on Feb 24, 2026, covering fiscal Q4 2025.
Did PCVX beat earnings estimates?
No. Vaxcyte reported EPS of −$1.81 for Q4 2025 against a −$1.53 estimate — a 18.32% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.